Terns Pharmaceuticals, Inc. (TERN)

Terns Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	May 1, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Market Cap	6,114	4,538	483	419	547	179
Market Cap Growth	2817.95%	840.15%	15.17%	-23.37%	206.12%	-
Enterprise Value	5,095	3,519	125.44	155.66	264.33	12.83
Last Close Price	52.95	40.40	5.54	6.49	10.18	7.07
PS Ratio	-	-	-	-	-	178.65
PB Ratio	5.91	4.51	1.40	1.64	1.97	1.11
P/TBV Ratio	4.90	3.74	1.27	1.81	1.33	1.00
EV/Sales Ratio	-	-	-	-	-	12.83
Debt / Equity Ratio	0.00	0.00	0.00	0	0.00	0.00
Net Debt / Equity Ratio	-1.01	-1.01	-1.03	-1.03	-1.02	-1.03
Net Debt / EBITDA Ratio	9.29	9.29	3.53	2.59	4.62	3.36
Net Debt / FCF Ratio	12.39	12.39	5.09	3.90	5.71	3.93
Asset Turnover	-	0	0	0	0	0.01
Quick Ratio	62.09	62.09	22.89	22.06	33.43	24.34
Current Ratio	62.41	62.41	23.14	22.39	33.68	24.48
Return on Equity (ROE)	-14.23%	-14.23%	-29.56%	-33.89%	-27.60%	-43.83%
Return on Assets (ROA)	-15.95%	-15.95%	-32.31%	-37.02%	-27.42%	-38.69%
Return on Invested Capital (ROIC)	1148.23%	1148.23%	1299.79%	2024.42%	1446.60%	-3646.05%
Return on Capital Employed (ROCE)	-16.23%	-16.23%	-33.68%	-38.33%	-28.21%	-43.22%
Buyback Yield / Dilution	-17.18%	-17.18%	-11.58%	-97.76%	-58.69%	-7862.46%
Total Shareholder Return	-17.18%	-17.18%	-11.58%	-97.76%	-58.69%	-7862.46%

Updated Mar 30, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q